Literature DB >> 31962053

Epidemiology of major chronic inflammatory immune-related skin diseases in 2019.

Elena Pezzolo1,2, Luigi Naldi1,2.   

Abstract

Introduction: 'Chronic inflammatory immune-related skin disease' (ISDs) is an umbrella term grouping together heterogeneous entities characterized by chronic inflammation potentially involving the whole skin. We are not covering all ISDs in this review, but take a few as the most representative, including nonbullous and bullous diseases. The question we are aiming to address can be summarized as follows: 'despite the differences, is it possible to define some unifying epidemiologic characteristics and shared progression pathways which can guide the organization of healthcare?'Areas covered: This review covers incidence, prevalence, risk factors and prognosis of psoriasis, atopic dermatitis (AD), pemphigus and pemphigoid. Medline, Embase and the Cochrane Library were searched for papers published between January 2005 and December 2019.Expert opinion: ISDs epidemiology varies according to the ISD type, age, sex, climate, and sociodemographic variables. AD and psoriasis pose a considerable public health burden owing to their high prevalence worldwide and morbidity. Their secular trend of increasing incidence points to a role for environmental factors and gene-environment interactions. Bullous diseases are much rarer, with limited data available. Worldwide, the leading cause of skin disease disability-adjusted life-years (DALYs) is attributable to AD. Future research should focus on risk factors and prevention at the global level.

Entities:  

Keywords:  Atopic dermatitis; bullous diseases; inflammatory diseases; pemphigoid; pemphigus; psoriasis

Mesh:

Year:  2020        PMID: 31962053     DOI: 10.1080/1744666X.2020.1719833

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  9 in total

1.  Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivo.

Authors:  Qing Wu; Xiumei Mo; Ying Lin; Junfeng Liu; Siqi Ye; Yu Zhang; Xingxing Fan; Dacan Chen; Fenggen Yan
Journal:  Ann Transl Med       Date:  2022-09

2.  Cytokine induced 3-D organotypic psoriasis skin model demonstrates distinct roles for NF-κB and JAK pathways in disease pathophysiology.

Authors:  Viktor Todorović; Heath A McDonald; Paul Hoover; Joseph B Wetter; Anastasia E Marinopoulos; Clarissa L Woody; Loan Miller; Ariel Finkielsztein; Robert W Dunstan; Amy S Paller; Prisca Honore; Spiro Getsios; Victoria E Scott
Journal:  Exp Dermatol       Date:  2022-03-07       Impact factor: 4.511

3.  The Protective Effects of 18β-Glycyrrhetinic Acid on Imiquimod-Induced Psoriasis in Mice via Suppression of mTOR/STAT3 Signaling.

Authors:  Haiming Chen; Huazhen Liu; Bin Tang; Yuchao Chen; Ling Han; Jingjie Yu; Yuhong Yan; Chuanjian Lu
Journal:  J Immunol Res       Date:  2020-08-27       Impact factor: 4.818

Review 4.  Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis.

Authors:  Cristina Membrive Jiménez; Cristina Pérez Ramírez; Almudena Sánchez Martín; Sayleth Vieira Maroun; Salvador Antonio Arias Santiago; María Del Carmen Ramírez Tortosa; Alberto Jiménez Morales
Journal:  J Pers Med       Date:  2021-04-12

5.  Serum vitamin E levels and chronic inflammatory skin diseases: A systematic review and meta-analysis.

Authors:  Xiaofang Liu; Guang Yang; Mengxin Luo; Qi Lan; Xiaoxia Shi; Haoyuan Deng; Ningning Wang; Xuezhu Xu; Cong Zhang
Journal:  PLoS One       Date:  2021-12-14       Impact factor: 3.240

Review 6.  Current Concepts of Psoriasis Immunopathogenesis.

Authors:  Marijana Vičić; Marija Kaštelan; Ines Brajac; Vlatka Sotošek; Larisa Prpić Massari
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

Review 7.  Skin Immunosenescence and Type 2 Inflammation: A Mini-Review With an Inflammaging Perspective.

Authors:  Bangtao Chen; Jing Yang; Yao Song; Daojun Zhang; Fei Hao
Journal:  Front Cell Dev Biol       Date:  2022-02-24

8.  Reactive Oxygen Species-Responsive Polymer Nanoparticles to Improve the Treatment of Inflammatory Skin Diseases.

Authors:  Heidi K Noddeland; Pernille Kemp; Andrew J Urquhart; Andreas Herchenhan; Klaus A Rytved; Karsten Petersson; Louise B Jensen
Journal:  ACS Omega       Date:  2022-07-15

9.  Haplopine Ameliorates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis-Like Skin Lesions in Mice and TNF-α/IFN-γ-Induced Inflammation in Human Keratinocyte.

Authors:  Tae-Young Kim; Ye Jin Kim; Jonghwan Jegal; Beom-Geun Jo; Han-Seok Choi; Min Hye Yang
Journal:  Antioxidants (Basel)       Date:  2021-05-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.